---
title: "Weekly Recap | Ping An Biomedical -6.2%, a messy, high-volatility week"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298101290.md"
description: "Ping An Biomedical (PASW.US) had a rough week, falling 6.2% to close at $0.1226, underperforming the S&P 500 by about 6.29 percentage points. In fact, the stock opened on Monday (31 Aug) at $0.14, briefly spiked to $0.24, and then gave back most of that move over the following four sessions. Friday (4 Sep) saw a pullback from the open at $0.1220 to a low of $0.1151 before settling at $0.1226."
datetime: "2026-09-05T07:47:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298101290.md)
  - [en](https://longbridge.com/en/news/298101290.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298101290.md)
generator: "portal-rs"
---

# Weekly Recap | Ping An Biomedical -6.2%, a messy, high-volatility week

## The Week

Ping An Biomedical (PASW.US) had a rough week, falling 6.2% to close at $0.1226, underperforming the S&P 500 by about 6.29 percentage points. In fact, the stock opened on Monday (31 Aug) at $0.14, briefly spiked to $0.24, and then gave back most of that move over the following four sessions. Friday (4 Sep) saw a pullback from the open at $0.1220 to a low of $0.1151 before settling at $0.1226. Volume remained concentrated in Monday’s blow-off, with roughly 362 million shares traded for the week, while the subsequent days saw a sharp drop-off in turnover.

## Key Events

News flow this week revolved around 1 Sep (Tuesday). Pre-market screens showed Ping An Biomedical down 13.39%, while a midday update put the decline at 16.42%, with one headline citing ‘capital demanding more from the industry’ as a reason for valuation pressure. Two commentary pieces on the same day cast the stock as part of the ‘periphery’ or ‘island of misfit toys’ theme: one focused on AI and business transformation, the other on questionable players in a hot market. These are more sentiment and framing than company-specific announcements, as no earnings, regulatory or product updates hit the tape this week.

## The Week Ahead

The upcoming macro calendar is front-loaded around 8–10 Sep. On 8 Sep (Tuesday), the NFIB Small Business Optimism Index arrives with a prior of 99.8. 10 Sep (Thursday) is the busiest, featuring initial jobless claims, the PPI and core PPI prints, existing home sales, wholesale sales, and the 10-year Treasury auction. A softer inflation or labour read could shift risk appetite, which matters for a low-priced, high-volatility stock like PASW.US.

## In Short

This week’s message is a mix of high volatility and low conviction. The stock fell 6.2% but swung nearly 89% from peak to trough, so the decline understates the noise. The price-to-book ratio sits at around 2.4x, earnings are negative, and the latest daily turnover rate is just 0.73%, leaving the stock thinly traded. Intraday capital-flow data showed small and medium orders slightly tilted toward buying, but with zero large-order activity, the picture is fragmented. The real test next week is whether this thinly traded name can hold its lower range through a dense macro calendar.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [PASW.US](https://longbridge.com/en/quote/PASW.US.md)

## Related News & Research

- [Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years | PASW Stock News](https://longbridge.com/en/news/293483973.md)
- [Micron Stock's (MU) AI Lead Is Expanding beyond HBM. I'm Bullish](https://longbridge.com/en/news/299626350.md)
- [Greenland Resources eyes US exchange listing after US-Denmark deal](https://longbridge.com/en/news/299663759.md)
- [Michael Saylor Says, 'A Little More Orange': Will Strategy Report BTC Purchases After Hitting Pause for 3 Weeks?](https://longbridge.com/en/news/299601303.md)
- [Jensen Huang Says AI CEOs May Have 'Ulterior', Maybe 'Political' Reasons For AI Doomsday Warnings: 'Go and Read Between The Lines'](https://longbridge.com/en/news/299637656.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**